kf 17837s has been researched along with benserazide in 1 studies
| Studies (kf 17837s) | Trials (kf 17837s) | Recent Studies (post-2010) (kf 17837s) | Studies (benserazide) | Trials (benserazide) | Recent Studies (post-2010) (benserazide) |
|---|---|---|---|---|---|
| 39 | 0 | 0 | 1,113 | 162 | 156 |
| Protein | Taxonomy | kf 17837s (IC50) | benserazide (IC50) |
|---|---|---|---|
| Genome polyprotein | Coxsackievirus B3 (strain Nancy) | 2.4 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.14 | |
| Hexokinase-2 | Homo sapiens (human) | 5.52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanda, T; Nakamura, J; Shimada, J; Shiozaki, S; Suzuki, F | 1 |
1 other study(ies) available for kf 17837s and benserazide
| Article | Year |
|---|---|
KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.
Topics: Adenosine; Administration, Oral; Animals; Antihypertensive Agents; Benserazide; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Mice; Phenethylamines; Purinergic Antagonists; Xanthines | 1994 |